246 related articles for article (PubMed ID: 15894466)
21. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
Abdallah BM; Beck-Nielsen H; Gaster M
Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
[TBL] [Abstract][Full Text] [Related]
22. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
Simoneau JA; Kelley DE
J Appl Physiol (1985); 1997 Jul; 83(1):166-71. PubMed ID: 9216960
[TBL] [Abstract][Full Text] [Related]
23. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity.
Ritov VB; Menshikova EV; Azuma K; Wood R; Toledo FG; Goodpaster BH; Ruderman NB; Kelley DE
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E49-58. PubMed ID: 19887598
[TBL] [Abstract][Full Text] [Related]
24. Impaired glucose partitioning in primary myotubes from severely obese women with type 2 diabetes.
Zou K; Turner K; Zheng D; Hinkley JM; Kugler BA; Hornby PJ; Lenhard J; Jones TE; Pories WJ; Dohm GL; Houmard JA
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1011-C1019. PubMed ID: 32966127
[TBL] [Abstract][Full Text] [Related]
25. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes.
Gaster M; Rustan AC; Aas V; Beck-Nielsen H
Diabetes; 2004 Mar; 53(3):542-8. PubMed ID: 14988236
[TBL] [Abstract][Full Text] [Related]
26. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid oxidation by skeletal muscle homogenates from morbidly obese black and white American women.
Privette JD; Hickner RC; Macdonald KG; Pories WJ; Barakat HA
Metabolism; 2003 Jun; 52(6):735-8. PubMed ID: 12800100
[TBL] [Abstract][Full Text] [Related]
28. The diabetic phenotype is preserved in myotubes established from type 2 diabetic subjects: a critical appraisal.
Gaster M
APMIS; 2019 Jan; 127(1):3-26. PubMed ID: 30549138
[TBL] [Abstract][Full Text] [Related]
29. Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids.
Corpeleijn E; Hessvik NP; Bakke SS; Levin K; Blaak EE; Thoresen GH; Gaster M; Rustan AC
Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E14-22. PubMed ID: 20442319
[TBL] [Abstract][Full Text] [Related]
30. Changes in skeletal muscle mitochondria in response to the development of type 2 diabetes or prevention by daily wheel running in hyperphagic OLETF rats.
Rector RS; Uptergrove GM; Borengasser SJ; Mikus CR; Morris EM; Naples SP; Laye MJ; Laughlin MH; Booth FW; Ibdah JA; Thyfault JP
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1179-87. PubMed ID: 20233940
[TBL] [Abstract][Full Text] [Related]
31. Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype?
Gaster M
Biochem Biophys Res Commun; 2009 Oct; 387(4):651-5. PubMed ID: 19615969
[TBL] [Abstract][Full Text] [Related]
32. A primary reduced TCA flux governs substrate oxidation in T2D skeletal muscle.
Gaster M
Curr Diabetes Rev; 2012 Nov; 8(6):458-79. PubMed ID: 22934552
[TBL] [Abstract][Full Text] [Related]
33. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.
Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H
Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987
[TBL] [Abstract][Full Text] [Related]
34. FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle.
Holloway GP; Jain SS; Bezaire V; Han XX; Glatz JF; Luiken JJ; Harper ME; Bonen A
Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R960-7. PubMed ID: 19625692
[TBL] [Abstract][Full Text] [Related]
35. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
36. Primary defects in lipid handling and resistance to exercise in myotubes from obese donors with and without type 2 diabetes.
Løvsletten NG; Rustan AC; Laurens C; Thoresen GH; Moro C; Nikolić N
Appl Physiol Nutr Metab; 2020 Feb; 45(2):169-179. PubMed ID: 31276628
[TBL] [Abstract][Full Text] [Related]
37. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.
Bruce CR; Anderson MJ; Carey AL; Newman DG; Bonen A; Kriketos AD; Cooney GJ; Hawley JA
J Clin Endocrinol Metab; 2003 Nov; 88(11):5444-51. PubMed ID: 14602787
[TBL] [Abstract][Full Text] [Related]
38. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
[TBL] [Abstract][Full Text] [Related]
39. Myotubes from lean and severely obese subjects with and without type 2 diabetes respond differently to an in vitro model of exercise.
Feng YZ; Nikolić N; Bakke SS; Kase ET; Guderud K; Hjelmesæth J; Aas V; Rustan AC; Thoresen GH
Am J Physiol Cell Physiol; 2015 Apr; 308(7):C548-56. PubMed ID: 25608533
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of glucose metabolism in human myotubes by supraphysiological doses of 17β-estradiol or testosterone.
Garrido P; Salehzadeh F; Duque-Guimaraes DE; Al-Khalili L
Metabolism; 2014 Sep; 63(9):1178-87. PubMed ID: 25034385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
